#aahth ,,congress #b;d ,session ,h4 ,r4 #dgeh ,,an ,,act ,to amend title ,,xix of the ,social ,security ,act to streamline enrollment under the ,medicaid program of certain providers across ,state lines1 and to prevent the use of abusive spread pricing in ,medicaid4 #a4 ,short title ,this ,act may be cited as the ,accelerating ,kids' ,access to ,care ,act4 #b4 ,streamlined enrollment process for eligible out-of-,state providers under medicaid and chip 7a7 ,in general ,section #aijb7kk7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;a7kk77 is amended by adding at the end the following new paragraph3 7#aj7 ,streamlined enrollment process for eligible out-of-,state providers 7,a7 ,in general ,the ,state-- 7i7 adopts and implements a process to allow an eligible out-of-,state provider to enroll under the ,state plan 7or a waiver of such plan7 to furnish items and services to1 or order1 prescribe1 refer1 or certify eligibility for items and services for1 qualifying individuals without the imposition of screening or enrollment requirements in addition to those imposed by the ,state in which the eligible out-of-,state provider is located2 and 7ii7 provides that an eligible out-of-,state provider that enrolls as a participating provider in the ,state plan 7or a waiver of such plan7 through such process shall be so enrolled for a #e-year period1 unless the provider is terminated or excluded from participation during such period4 7,b7 ,definitions ,in this paragraph3 7i7 ,eligible out-of-,state provider ,the term eligible out-of-,state provider means1 with respect to a ,state1 a provider-- 7,i7 that is located in any other ,state2 7,,ii7 that-- 7aa7 was determined by the ,secretary to have a limited risk of fraud1 waste1 and abuse for purposes of determining the level of screening to be conducted under section #ahff7;j77#b71 has been so screened under such section #ahff7;j77#b71 and is enrolled in the ,medicare program under title ,,xviii2 or 7bb7 was determined by the ,state agency administering or supervising the administration of the ,state plan 7or a waiver of such plan7 of such other ,state to have a limited risk of fraud1 waste1 and abuse for purposes of determining the level of screening to be conducted under paragraph 7#a7 of this subsection1 has been so screened under such paragraph 7#a71 and is enrolled under such ,state plan 7or a waiver of such plan72 and 7,,iii7 that has not been-- 7aa7 excluded from participation in any ,federal health care program pursuant to section #aabh or #aabh;,a2 7bb7 excluded from participation in the ,state plan 7or a waiver of such plan7 pursuant to part #ajjb of title #db1 ,code of ,federal ,regulations 7or any successor regulation71 or ,state law2 or 7cc7 terminated from participating in a ,federal health care program or the ,state plan 7or a waiver of such plan7 for a reason described in paragraph 7#h77;,a74 7ii7 ,qualifying individual ,the term qualifying individual means an individual under #ba years of age who is enrolled under the ,state plan 7or waiver of such plan74 7iii7 ,state ,the term ,state means #a of the #ej ,states or the ,district of ,columbia4 4 7b7 ,conforming amendments 7#a7 ,section #aijb7;a77#gg7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;a7a77#gg77 is amended by inserting enrollment1 after screening14 7#b7 ,the subsection heading for section #aijb7kk7 of such ,act 7#db ,u4,s4,c4 #acif;a7kk77 is amended by inserting enrollment1 after screening14 7#c7 ,section #bajg7;e77#a77;,g7 of such ,act 7#db ,u4,s4,c4 #acig;gg7e77#a77;,g77 is amended by inserting enrollment1 after screening14 7c7 ,effective date ,the amendments made by this section shall take effect on the date that is #c years after the date of enactment of this section4 #c4 ,preventing the use of abusive spread pricing in medicaid 7a7 ,in general ,section #aibg of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7 is amended-- 7#a7 in subsection 7e71 by adding at the end the following new paragraph3 7#f7 ,transparent prescription drug pass-through pricing required 7,a7 ,in general ,a contract between the ,state and a pharmacy benefit manager 7referred to in this paragraph as a ,,pbm71 or a contract between the ,state and a managed care entity or other specified entity 7as such terms are defined in section #aijc7m77#i77;,d7 and collectively referred to in this paragraph as the entity7 that includes provisions making the entity responsible for coverage of covered outpatient drugs dispensed to individuals enrolled with the entity1 shall require that payment for such drugs and related administrative services 7as applicable71 including payments made by a ,,pbm on behalf of the ,state or entity1 is based on a transparent prescription drug pass-through pricing model under which-- 7i7 any payment made by the entity or the ,,pbm 7as applicable7 for such a drug-- 7,i7 is limited to-- 7aa7 ingredient cost2 and 7bb7 a professional dispensing fee that is not less than the professional dispensing fee that the ,state would pay if the ,state were making the payment directly in accordance with the ,state plan2 7,,ii7 is passed through in its entirety 7except as reduced under ,federal or ,state laws and regulations in response to instances of waste1 fraud1 or abuse7 by the entity or ,,pbm to the pharmacy or provider that dispenses the drug2 and 7,,iii7 is made in a manner that is consistent with sections #ddg4ejb1 #ddg4eab1 #ddg4ead1 and #ddg4eah of title #db1 ,code of ,federal ,regulations 7or any successor regulation7 as if such requirements applied directly to the entity or the ,,pbm1 except that any payment by the entity or the ,,pbm for the ingredient cost of such drug purchased by a covered entity 7as defined in subsection 7a77#e77;,b77 may exceed the actual acquisition cost 7as defined in #ddg4ejb of title #db1 ,code of ,federal ,regulations1 or any successor regulation7 for such drug if-- 7aa7 such drug was subject to an agreement under section #cdj;,b of the ,public ,health ,service ,act2 7bb7 such payment for the ingredient cost of such drug does not exceed the maximum payment that would have been made by the entity or the ,,pbm for the ingredient cost of such drug if such drug had not been purchased by such covered entity2 and 7cc7 such covered entity reports to the ,secretary 7in a form and manner specified by the ,secretary71 on an annual basis and with respect to payments for the ingredient costs of such drugs so purchased by such covered entity that are in excess of the actual acquisition costs for such drugs1 the aggregate amount of such excess2 7ii7 payment to the entity or the ,,pbm 7as applicable7 for administrative services performed by the entity or ,,pbm is limited to an administrative fee that reflects the fair market value 7as defined by the ,secretary7 of such services2 7iii7 the entity or the ,,pbm 7as applicable7 makes available to the ,state1 and the ,secretary upon request in a form and manner specified by the ,secretary1 all costs and payments related to covered outpatient drugs and accompanying administrative services 7as described in clause 7ii77 incurred1 received1 or made by the entity or the ,,pbm1 broken down 7as specified by the ,secretary71 to the extent such costs and payments are attributable to an individual covered outpatient drug1 by each such drug1 including any ingredient costs1 professional dispensing fees1 administrative fees 7as described in clause 7ii771 post-sale and post-invoice fees1 discounts1 or related adjustments such as direct and indirect remuneration fees1 and any and all other remuneration2 and 7iv7 any form of spread pricing whereby any amount charged or claimed by the entity or the ,,pbm 7as applicable7 that exceeds the amount paid to the pharmacies or providers on behalf of the ,state or entity1 including any post-sale or post-invoice fees1 discounts1 or related adjustments such as direct and indirect remuneration fees or assessments 7after allowing for an administrative fee as described in clause 7ii77 is not allowable for purposes of claiming ,federal matching payments under this title4 7,b7 ,making certain information available ,the ,secretary shall publish1 not less frequently than on an annual basis1 information received by the ,secretary pursuant to subparagraph 7,a77i77,,iii77cc74 ,such information shall be so published in an electronic and searchable format1 such as through the #cdj;,b ,office of ,pharmacy ,affairs ,information ,system 7or a successor system74 2 and 7#b7 in subsection 7k71 by adding at the end the following new paragraph3 7#ab7 ,pharmacy benefit manager ,the term pharmacy benefit manager means any person or entity that1 either directly or through an intermediary1 acts as a price negotiator or group purchaser on behalf of a ,state1 managed care entity 7as defined in section #aijc7m77#i77;,d771 or other specified entity 7as so defined71 and may also more broadly manage aspects of the prescription drug benefits provided by a ,state1 managed care entity1 or other specified entity1 including the processing and payment of claims for prescription drugs1 the performance of drug utilization review1 the processing of drug prior authorization requests1 the managing of appeals or grievances related to the prescription drug benefits1 contracting with pharmacies1 controlling the cost of covered outpatient drugs1 or the provision of services related thereto4 ,such term includes any person or entity that acts as a price negotiator 7with regard to payment amounts to pharmacies and providers for a covered outpatient drug or the net cost of the drug7 or group purchaser on behalf of a ,state1 managed care entity1 or other specified entity1 including such a person or entity that carries out #a or more of the other activities described in the preceding sentence1 irrespective of whether such person or entity calls itself a pharmacy benefit manager4 4 7b7 ,conforming amendments ,section #aijc7m7 of such ,act 7#db ,u4,s4,c4 #acif;b7m77 is amended-- 7#a7 in paragraph 7#b77;,a77xiii7-- 7,a7 by striking and 7,,iii7 and inserting 7,,iii72 7,b7 by inserting before the period at the end the following3 1 and 7,,iv7 if the contract includes provisions making the entity responsible for coverage of covered outpatient drugs1 the entity shall comply with the requirements of section #aibg7;e77#f72 and 7,c7 by moving the left margin #b ems to the left2 and 7#b7 by adding at the end the following new paragraph3 7#aj7 ,no payment shall be made under this title to a ,state with respect to expenditures incurred by the ,state for payment for services provided by an other specified entity 7as defined in paragraph 7#i77;,d77iii77 unless such services are provided in accordance with a contract between the ,state and such entity which satisfies the requirements of paragraph 7#b77;,a77xiii74 4 7c7 ,effective date ,the amendments made by this section shall apply to contracts between ,states and managed care entities1 other specified entities1 or pharmacy benefit managers that have an effective date beginning on or after the date that is #ah months after the date of enactment of this ,act4 7d7 ,implementation 7#a7 ,in general ,notwithstanding any other provision of law1 the ,secretary of ,health and ,human ,services may implement the amendments made by this section by program instruction or otherwise4 7#b7 ,nonapplication of administrative procedure act ,implementation of the amendments made by this section shall be exempt from the requirements of section #eec of title #e1 ,united ,states ,code4 7e7 ,nonapplication of paperwork reduction act ,chapter #ce of title #dd1 ,united ,states ,code1 shall not apply to any data collection undertaken by the ,secretary of ,health and ,human ,services under section #aibg7;e7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifr-#h7;f771 as amended by this section4 #d4 ,medicaid improvement fund ,section #aida7;b77#c77;,a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acifw-#a7;b77#c77;,a77 is amended by striking #j and inserting #fi1jjj1jjj4 ,passed the ,house of ,representatives ,september #ag1 #bjbd4;,clerk4